Mesoblast (MESO) Asset Utilization Ratio (2017 - 2023)
Mesoblast recorded quarterly Asset Utilization Ratio of 0.01 in Q1 2023, up 1.62% quarter-over-quarter from 0.01 in Q4 2022, and down 9.49% year-over-year from 0.01 in Q1 2022.
Mesoblast's Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.01 for Q1 2023.
- In Q1 2023, Asset Utilization Ratio fell 9.49% year-over-year to 0.01; the TTM figure through Mar 2023 stood at 0.01 (down 9.49% YoY), while the FY2025 annual figure was 0.02, changed N/A from the prior year.
- Asset Utilization Ratio came in at 0.01 for Q1 2023 at Mesoblast, up from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q2 2020 to a low of 0.01 in Q1 2019.
- A 5-year average of 0.02 and a median of 0.01 in 2021 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio soared 483.17% in 2020 and tumbled 78.4% in 2021, its largest moves.
- Mesoblast's Asset Utilization Ratio stood at 0.01 in 2019, then surged by 346.56% to 0.05 in 2020, then slumped by 73.02% to 0.01 in 2021, then dropped by 7.8% to 0.01 in 2022, then rose by 1.62% to 0.01 in 2023.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.85 |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | 0.04 |
| Jun 30, 2020 | 0.05 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.01 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.01 |
| Sep 30, 2017 | 0.00 |
| Jun 30, 2017 | 0.00 |
| Mar 31, 2017 | 0.04 |